Get started
Author

Ravinder Phul

Observed names: Phul, R., Phul, Ravinder, R Phul
OpenAlex ID: A5018123784
Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial
2022 · Messoud Ashina, Michel Lanteri-Minet, et al. · The Lancet Neurology · 147
A Monoclonal Antibody to PACAP for Migraine Prevention
2024 · Messoud Ashina, Ravinder Phul, et al. · New England Journal of Medicine · 103
Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures
2022 · Peter J. Goadsby, Piero Barbanti, et al. · European Journal of Neurology · 29
PDF
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study
2023 · Messoud Ashina, Michel Lanteri-Minet, et al. · Cephalalgia · 28
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study
2022 · Piero Barbanti, Peter J. Goadsby, et al. · The Journal of Headache and Pain · 20
PDF
Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed
2025 · Dimos D. Mitsikostas, Susanne F. Awad, et al. · Advances in Therapy · 2
PDF
American Headache Society 68th Annual Scientific Meeting June 4–7, 2026, Orlando, Florida
2026 · Ailani, J., Phul, R., et al. · Headache The Journal of Head and Face Pain
P.016 Impact of eptinezumab on patient-reported outcomes in patients with prior preventive treatment failures
2023 · PJ Goadsby, P Barbanti, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
P.014 Eptinezumab improved work productivity in adults with migraine and prior preventive treatment failures: results from the DELIVER study
2023 · PJ Goadsby, P Barbanti, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
Works count: 15
Citation count: 329
H-index: 5
I10-index: 5
Year
Topic
Type